India
· Delayed Price · Currency is INR Hester Biosciences Statistics
Total Valuation
Hester Biosciences has a market cap or net worth of INR 20.94 billion. The enterprise value is 23.34 billion.
| Market Cap | 20.94B |
| Enterprise Value | 23.34B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | Aug 22, 2024 |
Share Statistics
Hester Biosciences has 8.51 million shares outstanding. The number of shares has increased by 11.58% in one year.
| Shares Outstanding | 8.51M |
| Shares Change (YoY) | +11.58% |
| Shares Change (QoQ) | +9.38% |
| Owned by Insiders (%) | 62.37% |
| Owned by Institutions (%) | 0.37% |
| Float | 2.35M |
Valuation Ratios
The trailing PE ratio is 107.43.
| PE Ratio | 107.43 |
| Forward PE | n/a |
| PS Ratio | 6.80 |
| PB Ratio | 7.18 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 120.60 |
| EV / Sales | 7.64 |
| EV / EBITDA | 34.31 |
| EV / EBIT | 45.01 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 80.69 |
| Debt / EBITDA | 3.82 |
| Debt / FCF | n/a |
| Interest Coverage | 4.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 5.38% |
| Revenue Per Employee | 4.76M |
| Profits Per Employee | 301,495 |
| Employee Count | 642 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +40.44% |
| 50-Day Moving Average | 2,625.45 |
| 200-Day Moving Average | 1,856.80 |
| Relative Strength Index (RSI) | 47.15 |
| Average Volume (20 Days) | 871 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hester Biosciences had revenue of INR 3.06 billion and earned 193.56 million in profits. Earnings per share was 22.91.
| Revenue | 3.06B |
| Gross Profit | 2.17B |
| Operating Income | 477.61M |
| Pretax Income | 336.33M |
| Net Income | 193.56M |
| EBITDA | 637.49M |
| EBIT | 477.61M |
| Earnings Per Share (EPS) | 22.91 |
Balance Sheet
The company has 153.04 million in cash and 2.44 billion in debt, giving a net cash position of -2.29 billion or -269.28 per share.
| Cash & Cash Equivalents | 153.04M |
| Total Debt | 2.44B |
| Net Cash | -2.29B |
| Net Cash Per Share | -269.28 |
| Equity (Book Value) | 3.03B |
| Book Value Per Share | 343.01 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.89%, with operating and profit margins of 15.62% and 6.33%.
| Gross Margin | 70.89% |
| Operating Margin | 15.62% |
| Pretax Margin | 11.00% |
| Profit Margin | 6.33% |
| EBITDA Margin | 20.85% |
| EBIT Margin | 15.62% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.24%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 0.24% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.58% |
| Shareholder Yield | -11.33% |
| Earnings Yield | 0.93% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 27, 2012. It was a forward split with a ratio of 1.5.
| Last Split Date | Sep 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.5 |